PL374578A1 - Treatment of hepatitis c in the asian population with subcutaneous interferon beta - Google Patents

Treatment of hepatitis c in the asian population with subcutaneous interferon beta

Info

Publication number
PL374578A1
PL374578A1 PL03374578A PL37457803A PL374578A1 PL 374578 A1 PL374578 A1 PL 374578A1 PL 03374578 A PL03374578 A PL 03374578A PL 37457803 A PL37457803 A PL 37457803A PL 374578 A1 PL374578 A1 PL 374578A1
Authority
PL
Poland
Prior art keywords
hepatitis
treatment
interferon beta
asian population
subcutaneous interferon
Prior art date
Application number
PL03374578A
Other languages
English (en)
Polish (pl)
Inventor
Ian Parsons
Tit Gin Theodor Wee
Birgit Maschek
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of PL374578A1 publication Critical patent/PL374578A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL03374578A 2002-06-03 2003-05-28 Treatment of hepatitis c in the asian population with subcutaneous interferon beta PL374578A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02100632 2002-06-03

Publications (1)

Publication Number Publication Date
PL374578A1 true PL374578A1 (en) 2005-10-31

Family

ID=29595047

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374578A PL374578A1 (en) 2002-06-03 2003-05-28 Treatment of hepatitis c in the asian population with subcutaneous interferon beta

Country Status (21)

Country Link
US (1) US7344709B2 (ru)
EP (1) EP1509242A1 (ru)
JP (1) JP2005533035A (ru)
KR (1) KR20050008762A (ru)
CN (1) CN1671408A (ru)
AR (1) AR039915A1 (ru)
AU (1) AU2003250231B2 (ru)
BR (1) BR0311696A (ru)
CA (1) CA2487299A1 (ru)
EA (1) EA007091B1 (ru)
HR (1) HRP20041076A2 (ru)
IL (1) IL165521A (ru)
MX (1) MXPA04012043A (ru)
MY (1) MY139068A (ru)
NO (1) NO20045579L (ru)
PL (1) PL374578A1 (ru)
RS (1) RS105104A (ru)
TW (1) TWI334785B (ru)
UA (1) UA79615C2 (ru)
WO (1) WO2003101478A1 (ru)
ZA (1) ZA200409218B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200633718A (en) * 2004-12-16 2006-10-01 Applied Research Systems Treatment of hepatitis c in the asian population
JP5359883B2 (ja) * 2007-11-28 2013-12-04 東レ株式会社 肝炎の治療剤又は予防剤
US20100316608A1 (en) * 2009-06-15 2010-12-16 Vijayaprakash Suppiah Method of Determining A Response To Treatment With Immunomodulatory Composition
GB2506086A (en) 2011-10-21 2014-03-19 Abbvie Inc Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon
CA2811250C (en) 2011-10-21 2015-08-11 Abbvie Inc. Methods for treating hcv
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN102538594B (zh) * 2012-01-10 2013-12-25 西安工业大学 交汇式激光精度靶及其测试方法
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
ES2224649T3 (es) 1998-04-28 2005-03-01 Applied Research Systems Ars Holding N.V. Conjugados de poliol-ifn-beta.

Also Published As

Publication number Publication date
TWI334785B (en) 2010-12-21
AR039915A1 (es) 2005-03-09
WO2003101478A1 (en) 2003-12-11
CN1671408A (zh) 2005-09-21
ZA200409218B (en) 2006-02-22
RS105104A (en) 2007-02-05
US7344709B2 (en) 2008-03-18
NO20045579L (no) 2005-01-26
MY139068A (en) 2009-08-28
IL165521A (en) 2010-05-17
US20060029572A1 (en) 2006-02-09
EP1509242A1 (en) 2005-03-02
EA200401618A1 (ru) 2005-06-30
HRP20041076A2 (en) 2005-02-28
AU2003250231B2 (en) 2009-01-08
EA007091B1 (ru) 2006-06-30
BR0311696A (pt) 2005-03-22
TW200407159A (en) 2004-05-16
JP2005533035A (ja) 2005-11-04
CA2487299A1 (en) 2003-12-11
UA79615C2 (en) 2007-07-10
MXPA04012043A (es) 2005-03-07
AU2003250231A1 (en) 2003-12-19
KR20050008762A (ko) 2005-01-21
IL165521A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
ZA200409218B (en) Treatment of hepatitis C in the asian population with subcutaneous interferonbeta.
GB2388104B (en) Tray with built in utensil
EP1432430A4 (en) PREMIXTURES OF GLP-1 AND BASALINSULIN
EP1670485A4 (en) TREATMENT OF ILLNESSES ASSOCIATED WITH THE EGR-1 AMPLIFIER ELEMENT
HRP20041200A2 (en) Acidic insulin preparations with improved stability
HK1095765A1 (en) Interferon alpha antibodies and their uses
EP1536851A4 (en) MANUAL MILK POUCH COMPRISING A STIMULATING MEANS
AU2003228936A8 (en) Identification of dysregulated genes in patients with multiple sclerosis
AU2003236211A8 (en) Smac-peptides as therapeutics against cancer and autoimmune diseases
HUP0303534A3 (en) Modified interferon beta with reduced immunogenicity
EP1581631A4 (en) INTERFERON VARIANTS HAVING IMPROVED PROPERTIES
HUP0400464A3 (en) Adenosine analogues for treatment of the insulin resistance syndrome and diabetes
PL363181A1 (en) Modified interferon alpha with reduced immunogenicity
AU2001257422A1 (en) Use of d-chiro-inositol in the treatment of conditions associated with hypothalamic gene expression
IL172184A0 (en) Interferon gamma - like protein
IL148492A0 (en) Religious article with reinforced edges
EP1842857A4 (en) MUTANT PROTEINS OF INTERFERON AND THEIR USE
PL372534A1 (en) The treatment of pain with ifendropil
EP1498907A4 (en) GLASS FOR PROTECTION AGAINST RADIATION AND ARTICLE FOR PROTECTING RADIATION USING THE GLASS
EP1574575A4 (en) GLUCOSE AND / OR FRUCTOSETRANSPORTERS NaGLT1 AND ITS GEN
HUP0303523A3 (en) Modified insulin with reduced immunogenicity
AU2003251763A8 (en) Interferon gamma in the detection and treatment of angiomyolipomas
SI1311279T1 (sl) Zdravljenje hepatitisa c s timozinom, interferonom in ribavirinom
GB0218473D0 (en) Interferon-alpha induced gene
TW535592U (en) Structure of oven with medicine bath

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)